Search research articles
Contact Us
Filters
Showing results (21-30 of 105) with videos related to
Page
of 11
Sort By:
Journal of Cataract and Refractive Surgery
|
November 1, 1989
Effect of the laser ridge on posterior capsule opacification
B A Maltzman, E Haupt, P Cucci
Acta Haematologica
|
January 1, 1979
Multiple myeloma without detectable Ig synthesis
A M Ferraris, E Haupt, M Ratti
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
August 28, 2018
Physician Autonomy and the Opioid Crisis
Nathan Guevremont, Mark Barnes, Claudia E Haupt
Klinische Wochenschrift
|
July 15, 1977
[Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl)]
E Haupt, K A Küllmer, K Schöffling
Fortschritte Der Medizin
|
December 4, 1986
[Efficacy of an educational program for type I and type II diabetic patients. Results within the scope of an inpatient stay]
E Haupt, F U Hoppe, E Bamberg
Ophthalmic Surgery
|
May 1, 1989
Relationship between age at time of cataract extraction and time interval before capsulotomy for opacification
B A Maltzman, E Haupt, C Notis
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 1, 1974
Investigations on the antilipolytic activity of sulfonylureas in man with indications on limit dosages concerning their insulin-secreting properties
C Rosak, E Haupt, J Beyer, et al.
Medizinische Klinik
|
September 23, 1977
[Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)]
E Haupt, F Laube, H Loy, et al.
Diabetes, Nutrition & Metabolism
|
August 14, 2002
The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia
C Rosak, E Haupt, T Walter, et al.
Diabetologia
|
December 1, 1971
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects
E Haupt, W Köberich, J Beyer, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 105) with videos related to
Sort By:
Page
of 11
Journal of Cataract and Refractive Surgery
|
November 1, 1989
Effect of the laser ridge on posterior capsule opacification
B A Maltzman, E Haupt, P Cucci
Acta Haematologica
|
January 1, 1979
Multiple myeloma without detectable Ig synthesis
A M Ferraris, E Haupt, M Ratti
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
August 28, 2018
Physician Autonomy and the Opioid Crisis
Nathan Guevremont, Mark Barnes, Claudia E Haupt
Klinische Wochenschrift
|
July 15, 1977
[Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl)]
E Haupt, K A Küllmer, K Schöffling
Fortschritte Der Medizin
|
December 4, 1986
[Efficacy of an educational program for type I and type II diabetic patients. Results within the scope of an inpatient stay]
E Haupt, F U Hoppe, E Bamberg
Ophthalmic Surgery
|
May 1, 1989
Relationship between age at time of cataract extraction and time interval before capsulotomy for opacification
B A Maltzman, E Haupt, C Notis
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 1, 1974
Investigations on the antilipolytic activity of sulfonylureas in man with indications on limit dosages concerning their insulin-secreting properties
C Rosak, E Haupt, J Beyer, et al.
Medizinische Klinik
|
September 23, 1977
[Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)]
E Haupt, F Laube, H Loy, et al.
Diabetes, Nutrition & Metabolism
|
August 14, 2002
The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia
C Rosak, E Haupt, T Walter, et al.
Diabetologia
|
December 1, 1971
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects
E Haupt, W Köberich, J Beyer, et al.
Page
of 11